These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25391513)

  • 21. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009-2010 season.
    Tennis P; Toback SL; Andrews EB; McQuay LJ; Ambrose CS
    Vaccine; 2012 Sep; 30(42):6099-102. PubMed ID: 22841479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate influenza vaccine effectiveness in Victoria, Australia, 2011.
    Fielding JE; Grant KA; Tran T; Kelly HA
    Euro Surveill; 2012 Mar; 17(11):. PubMed ID: 22449867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine response following its simultaneous application with BCG 1st report.
    Zykov MP; Raphaelskaya TI
    Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serious adverse reactions should be further monitored after influenza A (H1N1) vaccination among children: postmarketing experience with 570,000 vaccinations between October 2009 and August 2010 in Guangzhou, China.
    Fu C; Xu J; Tan H; Wang M
    Pediatr Infect Dis J; 2011 Jul; 30(7):631-2. PubMed ID: 21673552
    [No Abstract]   [Full Text] [Related]  

  • 25. Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China.
    Liang XF; Li L; Liu DW; Li KL; Wu WD; Zhu BP; Wang HQ; Luo HM; Cao LS; Zheng JS; Yin DP; Cao L; Wu BB; Bao HH; Xu DS; Yang WZ; Wang Y
    N Engl J Med; 2011 Feb; 364(7):638-47. PubMed ID: 21288090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vaccination strategy for the flu prevention].
    Gil Á
    Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():10-4. PubMed ID: 20084341
    [No Abstract]   [Full Text] [Related]  

  • 27. Update on influenza A (H1N1) 2009 monovalent vaccines.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(39):1100-1. PubMed ID: 19816398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and safety of influenza vaccination in children: European perspective.
    Heikkinen T; Heinonen S
    Vaccine; 2011 Oct; 29(43):7529-34. PubMed ID: 21820481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population and risk group uptake of H1N1 influenza vaccine in mainland France 2009-2010: results of a national vaccination campaign.
    Bone A; Guthmann JP; Nicolau J; Lévy-Bruhl D
    Vaccine; 2010 Nov; 28(51):8157-61. PubMed ID: 20937310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No one is flu-proof.
    Aust Nurs Midwifery J; 2014 Apr; 21(9):6. PubMed ID: 24818266
    [No Abstract]   [Full Text] [Related]  

  • 31. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Weil-Olivier C; Lina B
    Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Haut Conseil de la Santé publique (HCSP). Guidance on the benefits and risks of the electronic cigarette or e-cigarette in the general population (February, 22, 2016)].
    Haut Conseil de la santé publique
    Rev Mal Respir; 2016 Jun; 33(6):509-25. PubMed ID: 27079863
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study.
    Jiménez-Jorge S; Savulescu C; Pozo F; de Mateo S; Casas I; Ledesma J; Larrauri A; ;
    Vaccine; 2012 May; 30(24):3595-602. PubMed ID: 22472792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonal influenza vaccination trends from 2007-2011 in privately insured children and adults in the United States.
    Antonova E; Ambrose CS; Kern D; Block SL; Caspard H; Tunceli O
    Vaccine; 2014 Nov; 32(48):6563-8. PubMed ID: 25045823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL; Toback SL; Yi T; Ambrose CS
    Clin Ther; 2009 Oct; 31(10):2140-7. PubMed ID: 19922885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 May; 58(19):521-4. PubMed ID: 19478718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Importance of influenza in the child. Intranasal influenza vaccine: another systematic vaccination?].
    Moraga Llop FA; Campins Martí M
    An Esp Pediatr; 2000 Oct; 53(4):299-304. PubMed ID: 11523509
    [No Abstract]   [Full Text] [Related]  

  • 39. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12.
    Kissling E; Valenciano M;
    Euro Surveill; 2012 Apr; 17(15):. PubMed ID: 22516046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons.
    Katayose M; Hosoya M; Haneda T; Yamaguchi H; Kawasaki Y; Sato M; Wright PF
    Vaccine; 2011 Feb; 29(9):1844-9. PubMed ID: 21195802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.